Integrating Telehealth to Advance Lung Cancer Screening

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorAbramson Cancer Center at Penn Medicine

About this trial

The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are:

1. Does patient outreach using synchronous and asynchronous telehealth strategies increase completion of SDM visits for LCS? 2. Is the effectiveness of these telehealth strategies similar by race and sex?

The study uses a Sequential Multiple Assignment Randomized Trial (SMART) design and includes two stages of interventions. The first stage of intervention includes direct patient outreach with an invitation to schedule either a 1) telehealth SDM visit or 2) telehealth or in-person SDM visit. Participants that do not respond to the first stage interventions receive a text message reminder encouraging SDM visit completion with or without digital care coordination.

Eligibility criteria

Qualifiers

are aged 50 to 80

have a history of tobacco use indicated by either: Documented 20 pack-year or greater smoking history in their electronic health record (EHR); OR Self-report via structured survey

currently smoke or formerly smoked cigarettes

have no documented history of lung cancer

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Active Choice
  • Telehealth Only
  • Low Touch Strategy
  • High Touch Strategy

Treatment groups

6,000 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Abramson Cancer Center at Penn Medicine

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Cancer Institute (NCI)

Collaborator